Advanced solid tumours
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
Who can joinAdults
Age18+ years
Kind of studyPhase 1: first tests of safety
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Where to go
4 hospitals in India taking patients for this trial.
Tata Memorial hospitalMumbai, MaharashtraDirections ↗
Noble Hospital Pvt. Ltd.Pune, MaharashtraDirections ↗
All India Institute for Medical SciencesDelhi, New DelhiDirections ↗
Pacific Medical College and HospitalUdaipur, RajasthanDirections ↗
Registry summary (technical)
This is a Phase 1 study of SBO-154 in patients with advanced cancers who are unable to tolerate or have not previously responded to standard therapy available in the country. The study involves multiple doses and takes place at several centers.
Sponsor: Sun Pharma Advanced Research Company Limited
NCT07042100 on ClinicalTrials.gov
Last updated on the registry 28 Jul 2026 · read by us 20 Oct 2026